The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.
The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments. However, the lack of awareness about allergy treatments restrains the market growth.The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them. According to a European survey in 2019, in Europe, the prevalence of allergic rhinitis ranges from 17 to 29%, whereas the prevalence of asthma varies from 1.3 to 11% among children and adults. Immunotherapy has shown positive and long-term benefits in allergic patients. In addition, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies. Also, developments in the pharmaceuticals industry have enabled companies to offer treatment for varied allergy reactions. Such developments in the food allergy treatment options and their effectiveness boost the growth of the Europe allergy treatment market.
The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Amid COVID-19 outbreak pandemic, it is discovered that a significant number of people across the world are suffering from chronic respiratory diseases such as respiratory allergies, allergic rhinitis, and sinusitis. EAACI, in collaboration with ARIA, in Europe has provided recommendations on operational plans and practical procedures for ensuring optimal standards in the daily clinical care of patients affected by allergic diseases. Therefore, the growing demand for allergy treatments in Europe boosts the growth of the allergy treatment market in the region.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE ALLERGY TREATMENT MARKET SEGMENTATION
By Allergy Type:
- Eye Allergy
- Rhinitis
- Asthma
- Skin Allergy
- Food Allergies
- Other Allergies
By Treatment:
- Anti-Allergy Drugs
- Antihistamines
- Corticosteroids
- Decongestants
- Other Drugs
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-Lingual Immunotherapy (SLIT)
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- LETI Pharma
- Dermapharm Holding Se
- Johnson and Johnson Services, Inc.
- Sanofi
- AbbVie's Inc.
- Pfizer
- ALK-Abelló A/S
- Allergy Therapeutics
- Stallergenes Greer
- GlaxoSmithKline PLC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Allergy Type and Treatment
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Allergy Treatment Market – By Allergy Type
1.3.2 Allergy Treatment Market – By Treatment
1.3.3 Allergy Treatment Market – By Country
2. Allergy Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Allergy Treatment Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Expert Opinion
5. Allergy Treatment Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Immunotherapy in Allergy Treatment
5.1.2 Developments in Food Allergy Treatments
5.2 Key Market Restraints
5.2.1 Lack of Awareness About Allergy Treatments
5.3 Key Market Opportunities
5.3.1 Growing Number of Allergy-Related Research Projects and Programs
5.4 Future Trends
5.4.1 Development and Approvals of Innovative Medicines such as Biologics for Treating Allergies and Asthma
5.5 Impact Analysis
6. Allergy Treatment Market – Europe Analysis
6.1 Europe Allergy Treatment Marker Revenue Forecast and Analysis
7. Allergy Treatment Market Analysis– by Allergy Type
7.1 Overview
7.2 Allergy Treatment Market, by Allergy Type 2020 & 2028 (%)
7.3 Eye Allergy
7.3.1 Overview
7.3.2 Eye Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Rhinitis
7.4.1 Overview
7.4.2 Rhinitis: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Asthma
7.5.1 Overview
7.5.2 Asthma: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Skin Allergy
7.6.1 Overview
7.6.2 Skin Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Food Allergies
7.7.1 Overview
7.7.2 Food Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Other Allergies
7.8.1 Overview
7.8.2 Other Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Allergy Treatment Market Analysis– by Treatment
8.1 Overview
8.2 Allergy Treatment Market, by Treatment 2020 & 2028 (%)
8.3 Anti-Allergy Drugs
8.3.1 Overview
8.3.2 Anti-Allergy Drugs: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.3 Antihistamines
8.3.3.1 Overview
8.3.3.2 Antihistamines: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.4 Corticosteroids
8.3.4.1 Overview
8.3.4.2 Corticosteroids: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.5 Decongestants
8.3.5.1 Overview
8.3.5.2 Decongestants: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.3.6 Other Drug
8.3.6.1 Overview
8.3.6.2 Other Drug: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunotherapy
8.4.1 Overview
8.4.2 Immunotherapy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4.3 Sub-cutaneous Immunotherapy (SCIT)
8.4.3.1 Overview
8.4.3.2 Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4.4 Sub-Lingual Immunotherapy (SLIT)
8.4.4.1 Overview
8.4.4.2 Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. Allergy Treatment Market – Europe Analysis
9.1 Europe: Allergy Treatment Market
9.1.1 Overview
9.1.2 Europe: Allergy Treatment Market, by Country, 2020 & 2028 (%)
9.1.3 Germany: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 Germany: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2 Germany: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.3.3 Germany: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.3.3.1 Germany: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.3.3.2 Germany: Allergy Treatment Market, by Immunotherapy 2019–2028 (USD Million)
9.1.4 UK: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.1 UK: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.2 UK: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.4.3 UK: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.4.3.1 UK: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.4.3.2 UK: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.5 France: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1 France: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2 France: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.5.3 France: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.5.3.1 France: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.5.3.2 France: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.6 Italy: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 Italy: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 Italy: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.6.3 Italy: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.6.3.1 Italy: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.6.3.2 Italy: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.7 Spain: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Spain: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Spain: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.7.3 Spain: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.7.3.1 Spain: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.7.3.2 Spain: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
9.1.8 Rest of Europe: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Rest of Europe: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Rest of Europe: Allergy Treatment Market, by Allergy Type, 2019–2028 (USD Million)
9.1.8.3 Rest of Europe: Allergy Treatment Market, by Treatment, 2019–2028 (USD Million)
9.1.8.3.1 Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2019–2028 (USD Million)
9.1.8.3.2 Rest of Europe: Allergy Treatment Market, by Immunotherapy, 2019–2028 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Allergy Treatment Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Allergy Treatment Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Johnson and Johnson Services, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sanofi
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AbbVie Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 LETI Pharma
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ALK-Abelló A/S
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Allergy Therapeutics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Stallergenes Greer
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GlaxoSmithKline plc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Dermapharm Holding
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 9. France: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. France: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 11. France: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 12. France: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Italy: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 15. Italy: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Allergy Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Allergy Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Allergy Treatment Market, by Immunotherapy – Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Allergy Treatment Market
LIST OF FIGURES
Figure 1. Allergy Treatment Market Segmentation
Figure 2. Allergy Treatment Market – By Country
Figure 3. Allergy Treatment Market Overview
Figure 4. Rhinitis Segment Held Largest Share of Allergy Treatment Market by Allergy Type
Figure 5. Anti-Allergy Drugs Segment Held Largest Share of Allergy Treatment Market by Treatment
Figure 6. Europe Allergy Treatment Market – Leading Country Markets (US$ Million)
Figure 7. Europe: PEST Analysis
Figure 8. Expert Opinion
Figure 9. Allergy Treatment Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Allergy Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Allergy Treatment Market, by Allergy Type 2020 & 2028 (%)
Figure 12. Eye Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Rhinitis: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asthma: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Skin Allergy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Food Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Other Allergies: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Allergy Treatment Market, by Treatment 2020 & 2028 (%)
Figure 19. Anti-Allergy Drugs: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Antihistamines: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Corticosteroids: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Decongestants: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Other Drug: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Immunotherapy: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe: Allergy Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. Europe: Allergy Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. Germany: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. UK: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. France: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Italy: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Spain: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Europe: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic on Allergy Treatment Market in European Countries
The List of Companies - Europe Allergy Treatment Market
- LETI Pharma
- Dermapharm Holding Se
- Johnson and Johnson Services, Inc.
- Sanofi
- AbbVie's Inc.
- Pfizer
- ALK-Abelló A/S
- Allergy Therapeutics
- Stallergenes Greer
- GlaxoSmithKline PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Allergy Treatment Market
May 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)